VJOncology is committed to improving our service to you

EAU 2020 | ProPSMA: PSMA-PET/CT imaging for high risk prostate cancer

VJOncology is committed to improving our service to you

Michael Hofman

Michael Hofman, MBBS, FRACP, FAANMS, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the results of the ProPSMA study, a prospective, randomized, multi-center trial of PSMA-PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter